Ligand Pharmaceuticals reported $76.65M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Agenus AGEN:US USD 13.46M 241K
Amgen AMGN:US USD 38.7B 2.18B
Baxter International BAX:US USD 16.43B 254M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Clovis Oncology CLVS:US USD 660.38M 13.49M
Eli Lilly And LLY:US USD 15.89B 925.4M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Glaxosmithkline GSK:US GBP 22.12B 4M
Harsco HSC:US USD 1.34B 18.16M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 807.82M 491K
Intrexon XON:US USD 82.07M 116.6M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Lannett LCI:US USD 619.34M 4.39M
Ligand Pharmaceuticals LGND:US USD 76.65M 38.38M
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Rigel Pharmaceuticals RIGL:US USD 39.47M 9.63M
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M
Veracyte VCYT:US USD 1.69M 46K